- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 0.21 | 310.35 | -4.73 | 0.39 | -23.01 | 0.39 | N/A | - | ||
| 2024/2 | 0.05 | -60.46 | -62.83 | 0.18 | -37.05 | 0.28 | N/A | 本月營收較去年同期減少 62.84%，主要係消化器類癌症用藥結束代理減少營收所致。 | ||
| 2024/1 | 0.13 | 26.97 | -13.27 | 0.13 | -13.27 | 0.35 | N/A | - | ||
| 2023/12 | 0.1 | -15.38 | -54.45 | 1.93 | -25.39 | 0.36 | 1.53 | 本月營收較去年同期減少54.46%，主要係健檢事業營收減少所致。 | ||
| 2023/11 | 0.12 | -13.13 | -57.15 | 1.83 | -22.65 | 0.39 | 1.42 | 本月營收較去年同期減少57.16%，主要係健檢事業營收減少所致。 | ||
| 2023/10 | 0.14 | 5.9 | -46.32 | 1.71 | -18.02 | 0.44 | 1.26 | - | ||
| 2023/9 | 0.13 | -21.98 | -41.97 | 1.57 | -14.03 | 0.5 | 1.22 | - | ||
| 2023/8 | 0.17 | -17.57 | -30.53 | 1.44 | -10.12 | 0.51 | 1.21 | - | ||
| 2023/7 | 0.2 | 49.01 | 50.81 | 1.27 | -6.51 | 0.56 | 1.09 | 本月營收較去年同期增加50.82%，主要係健檢事業營收增加所致。 | ||
| 2023/6 | 0.14 | -37.89 | -21.35 | 1.07 | -12.79 | 0.57 | 1.22 | - | ||
| 2023/5 | 0.22 | 3.94 | -6.26 | 0.93 | -11.38 | 0.65 | 1.06 | - | ||
| 2023/4 | 0.21 | -3.96 | -15.2 | 0.72 | -12.84 | 0.57 | 1.22 | - | ||
| 2023/3 | 0.22 | 60.09 | 12.21 | 0.5 | -11.82 | 0.5 | 1.61 | - | ||
| 2023/2 | 0.14 | -7.73 | 10.09 | 0.29 | -24.28 | 0.51 | 1.59 | - | ||
| 2023/1 | 0.15 | -33.31 | -41.22 | 0.15 | -41.22 | 0.65 | 1.24 | - | ||
| 2022/12 | 0.22 | -20.4 | 9.64 | 2.59 | -26.45 | 0.76 | 1.45 | - | ||
| 2022/11 | 0.28 | 8.82 | 29.34 | 2.36 | -28.66 | 0.76 | 1.45 | - | ||
| 2022/10 | 0.26 | 14.48 | 11.52 | 2.08 | -32.72 | 0.72 | 1.52 | - | ||
| 2022/9 | 0.22 | -6.59 | 11.75 | 1.83 | -36.27 | 0.6 | 2.1 | - | ||
| 2022/8 | 0.24 | 78.93 | -10.01 | 1.6 | -39.89 | 0.55 | 2.3 | - | ||
| 2022/7 | 0.13 | -22.29 | -33.17 | 1.36 | -43.22 | 0.54 | 2.33 | - | ||
| 2022/6 | 0.17 | -25.97 | -72.71 | 1.23 | -44.14 | 0.65 | 2.11 | 本月營收較去年同期減少 72.72%，主要係熟齡女性保健食品結束代理減少營收所致。 | ||
| 2022/5 | 0.23 | -5.96 | -29.62 | 1.05 | -32.56 | 0.68 | 2.04 | - | ||
| 2022/4 | 0.25 | 27.08 | -25.46 | 0.82 | -33.36 | 0.57 | 2.43 | - | ||
| 2022/3 | 0.2 | 57.07 | -35.12 | 0.57 | -36.28 | 0.57 | 1.8 | - | ||
| 2022/2 | 0.12 | -50.74 | -50.06 | 0.38 | -36.87 | 0.58 | 1.78 | 本月較去年同期減少50.07%，主係受新冠肺炎疫情亦趨嚴峻而影響營收所致。 | ||
| 2022/1 | 0.25 | 24.39 | -27.43 | 0.25 | -27.43 | 0.67 | 1.53 | - | ||
| 2021/12 | 0.2 | -6.1 | -20.15 | 3.52 | -2.55 | 0.65 | 1.69 | - | ||
| 2021/11 | 0.22 | -6.17 | -46.29 | 3.31 | -1.21 | 0.65 | 1.7 | - | ||
| 2021/10 | 0.23 | 14.72 | -32.9 | 3.1 | 4.93 | 0.7 | 1.57 | - | ||
| 2021/9 | 0.2 | -24.78 | -38.49 | 2.87 | 9.91 | 0.67 | 1.82 | - | ||
| 2021/8 | 0.27 | 32.87 | -5.88 | 2.66 | 16.84 | 1.1 | 1.11 | - | ||
| 2021/7 | 0.2 | -68.27 | -26.11 | 2.4 | 20.08 | 1.17 | 1.05 | - | ||
| 2021/6 | 0.63 | 90.95 | 121.48 | 2.2 | 27.36 | 1.3 | 1.06 | 本月營收較去年同期增加 121.49%，主要係熟齡女性保健食品銷售增加所致。 | ||
| 2021/5 | 0.33 | -0.4 | 26.47 | 1.56 | 8.65 | 0.97 | 1.42 | - | ||
| 2021/4 | 0.33 | 10.6 | 12.72 | 1.23 | 4.68 | 0.88 | 1.55 | - | ||
| 2021/3 | 0.3 | 20.9 | -8.06 | 0.9 | 1.98 | 0.9 | 2.04 | - | ||
| 2021/2 | 0.25 | -28.42 | -9.86 | 0.6 | 7.92 | 0.85 | 2.15 | - | ||
| 2021/1 | 0.35 | 36.88 | 25.69 | 0.35 | 25.69 | 1.0 | 1.82 | - | ||
| 2020/12 | 0.25 | -36.84 | -47.26 | 3.61 | -16.67 | 1.0 | 1.55 | - | ||
| 2020/11 | 0.4 | 17.22 | 39.62 | 3.35 | -12.84 | 1.07 | 1.44 | - | ||
| 2020/10 | 0.34 | 5.15 | -5.28 | 2.95 | -17.09 | 0.95 | 1.62 | - | ||
| 2020/9 | 0.33 | 15.09 | 23.5 | 2.61 | -18.43 | 0.88 | 1.63 | - | ||
| 2020/8 | 0.28 | 4.31 | -30.16 | 2.28 | -22.21 | 0.84 | 1.71 | - | ||
| 2020/7 | 0.27 | -4.89 | -20.46 | 2.0 | -20.93 | 0.82 | 1.76 | - | ||
| 2020/6 | 0.29 | 9.03 | -24.49 | 1.72 | -21.0 | 0.84 | 1.8 | - | ||
| 2020/5 | 0.26 | -11.23 | -28.88 | 1.44 | -20.27 | 0.89 | 1.72 | - | ||
| 2020/4 | 0.3 | -9.79 | -23.86 | 1.18 | -18.06 | 0.9 | 1.69 | - | ||
| 2020/3 | 0.33 | 18.52 | 7.02 | 0.88 | -15.91 | 0.88 | 1.61 | - | ||
| 2020/2 | 0.28 | -0.18 | 27.8 | 0.55 | -25.38 | 1.04 | 1.37 | - | ||
| 2020/1 | 0.28 | -42.57 | -47.28 | 0.28 | -47.28 | 1.05 | 1.36 | - | ||
| 2019/12 | 0.48 | 67.21 | 0.53 | 4.33 | -18.8 | 1.13 | 1.2 | - | ||
| 2019/11 | 0.29 | -20.47 | -21.14 | 3.85 | -20.71 | 0.92 | 1.49 | - | ||
| 2019/10 | 0.36 | 37.12 | -47.55 | 3.56 | -20.67 | 1.03 | 1.32 | - | ||
| 2019/9 | 0.26 | -34.92 | -36.13 | 3.2 | -15.78 | 1.01 | 1.15 | - | ||
| 2019/8 | 0.41 | 18.8 | -3.89 | 2.93 | -13.29 | 1.13 | 1.03 | - | ||
| 2019/7 | 0.34 | -9.7 | -31.16 | 2.53 | -14.63 | 1.09 | 1.06 | - | ||
| 2019/6 | 0.38 | 2.69 | -6.47 | 2.18 | -11.29 | 1.14 | 0.95 | - | ||
| 2019/5 | 0.37 | -4.97 | -19.31 | 1.8 | -12.24 | 0.0 | N/A | - | ||
| 2019/4 | 0.39 | 26.8 | 10.28 | 1.44 | -10.22 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 0.13 | 2023/1 | 0.15 | 2022/1 | 0.25 | 2021/1 | 0.35 | 2020/1 | 0.28 |
| 2024/2 | 0.05 | 2023/2 | 0.14 | 2022/2 | 0.12 | 2021/2 | 0.25 | 2020/2 | 0.28 |
| 2024/3 | 0.21 | 2023/3 | 0.22 | 2022/3 | 0.2 | 2021/3 | 0.3 | 2020/3 | 0.33 |
| N/A | N/A | 2023/4 | 0.21 | 2022/4 | 0.25 | 2021/4 | 0.33 | 2020/4 | 0.3 |
| N/A | N/A | 2023/5 | 0.22 | 2022/5 | 0.23 | 2021/5 | 0.33 | 2020/5 | 0.26 |
| N/A | N/A | 2023/6 | 0.14 | 2022/6 | 0.17 | 2021/6 | 0.63 | 2020/6 | 0.29 |
| N/A | N/A | 2023/7 | 0.2 | 2022/7 | 0.13 | 2021/7 | 0.2 | 2020/7 | 0.27 |
| N/A | N/A | 2023/8 | 0.17 | 2022/8 | 0.24 | 2021/8 | 0.27 | 2020/8 | 0.28 |
| N/A | N/A | 2023/9 | 0.13 | 2022/9 | 0.22 | 2021/9 | 0.2 | 2020/9 | 0.33 |
| N/A | N/A | 2023/10 | 0.14 | 2022/10 | 0.26 | 2021/10 | 0.23 | 2020/10 | 0.34 |
| N/A | N/A | 2023/11 | 0.12 | 2022/11 | 0.28 | 2021/11 | 0.22 | 2020/11 | 0.4 |
| N/A | N/A | 2023/12 | 0.1 | 2022/12 | 0.22 | 2021/12 | 0.2 | 2020/12 | 0.25 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
